| Followers | 1428 |
| Posts | 13771 |
| Boards Moderated | 1 |
| Alias Born | 09/16/2015 |
Thursday, June 15, 2023 2:02:43 PM
Excellent discovery of licenses/ patents $BDPT-
I admit that I still have a ton more discovery to do here but on the peripheral is looks strong with what they intend to come to market with and the spin off. THE KEY HERE IS USE OF. IMO- they don’t just have access to the patent - they have a LICENSE TO USE AND APPLY IT!!
I will delve into the filings tonight and tomorrow and give my analysis over the weekend.
The patents - if currently in use- should have the potential to generate excellent revenues so it would be great to see those updates. THE USE OF AI TO TREAT medical issues and things like Myopia is now BIG BUSINESS.
I admit that I still have a ton more discovery to do here but on the peripheral is looks strong with what they intend to come to market with and the spin off. THE KEY HERE IS USE OF. IMO- they don’t just have access to the patent - they have a LICENSE TO USE AND APPLY IT!!
I will delve into the filings tonight and tomorrow and give my analysis over the weekend.
The patents - if currently in use- should have the potential to generate excellent revenues so it would be great to see those updates. THE USE OF AI TO TREAT medical issues and things like Myopia is now BIG BUSINESS.
https://investorshub.advfn.com/$UPER-$TOCKS-DD-and-RESEARCH-FORUM-31721/
ALL POSTS are just opinion! Never BUY/SELL based on them! MUST consult licensed stock broker!
Recent BDPT News
- BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery • GlobeNewswire Inc. • 05/20/2026 08:15:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:16:04 PM
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night • GlobeNewswire Inc. • 04/28/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
